A program to reduce alcohol use among college students
Immediate and Long-term Efficacy of the Expectancy Challenge Alcohol Literacy Curriculum on Reducing Adverse Alcohol Outcomes
This study is testing a fun and interactive program that helps college students understand the real effects of drinking alcohol, with the goal of changing their expectations and reducing how much they drink.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Central Florida NIH-funded |
| Lab location | 1 site (Orlando, United States) |
| Project ID | NIH-10360244 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of the Expectancy Challenge Alcohol Literacy Curriculum (ECALC), an interactive program designed to educate college students about the consequences of alcohol consumption. The curriculum aims to challenge students' expectations about alcohol use through engaging activities, ultimately reducing their drinking behaviors. By focusing on the psychological factors that influence drinking, the program seeks to provide a cost-effective solution to a significant public health issue. Participants will engage in discussions and activities that promote critical thinking about alcohol use and its effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are college students who consume alcohol and are at risk of experiencing negative consequences from their drinking behaviors.
Not a fit: Patients who do not consume alcohol or are not enrolled in college may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a significant reduction in alcohol-related harms among college students.
How similar studies have performed: Previous research has shown that educational interventions targeting alcohol expectancies can be effective, although the specific approach of the ECALC is relatively novel.
Where this research is happening
Orlando, United States
- University of Central Florida — Orlando, United States (Active)
Researchers
- Principal investigator: Dunn, Michael E. — University of Central Florida
- Study coordinator: Dunn, Michael E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.